Evidence map›Paper›PMID 37577332›Full record

ArticleFrontiers in allergy2023

EUFOREA summit in Brussels 2023:

P W Hellings, S Lau, G K Scadding, L Bjermer, V Backer, A M Chaker, D M Conti, E De Corso, Z Diamant, R Djukanovic and 19 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Inter-societal Survey on the topical nasal treatments in Italy.Multidisciplinary respiratory medicine · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 14 countries.

P W HellingsDepartment of Otorhinolaryngology-Head and Neck Surgery, University Hospitals, Leuven, Belgium.
S LauDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin, Berlin, Germany.
G K ScaddingDepartment of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.
L BjermerDepartment of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
V BackerDepartment of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
A M ChakerDepartment of Otorhinolaryngology and Center for Allergy and Environment (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
D M ContiThe European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.
E De CorsoOtolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Z DiamantDepartment of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
R DjukanovicNIHR Southampton Biomedical Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
W FokkensDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
P GevaertUpper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium.
C L GrayDivision of Allergy, Department of Paediatrics and Child Health, University of Cape Town, Rondebosch, South Africa.
J K HanDepartment of Otolaryngology & Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, United States.
L G HeaneyWellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, United Kingdom.
H J HoffmannDepartment of Clinical Medicine, University of Aarhus, Aarhus, Denmark.
M JesenakDepartment of Pulmonology and Phthisiology, Department of Pediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia.
P JohansenDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
M S KumaranDepartment of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
M McDonaldMediclinic Sandton, Johannesburg, South Africa.
E MelénDepartment of Clinical Science and Education Södersjukhuset, Karolinska Institutet and Sachs' Children and Youth Hospital, Stockholm, Sweden.
J MullolRhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
S ReitsmaDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
D RyanAllergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
G ScaddingAllergy, Royal Brompton Hospital, London, United Kingdom.
P Schmid-GrendelmeierAllergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
T TeelingPatient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium.
M OdemyrPatient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium.
U WahnDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin, Berlin, Germany.
Forum of European National Highway Research Laboratories · BEAmsterdam University Medical Centers · NLCharité - Universitätsmedizin Berlin · DEGhent University · BERoyal Brompton Hospital · GBAarhus University · DKAgostino Gemelli University Polyclinic · ITComenius University Bratislava · SKEastern Virginia Medical School · USHospital Clínic de Barcelona · ESKarolinska Institutet · SEKlinikum rechts der Isar · DELund University · SENIHR Southampton Biomedical Research Centre · GBPost Graduate Institute of Medical Education and Research · INQueen's University Belfast · GBRigshospitalet · DKUniversity Hospital of Zurich · CHUniversity Medical Center Groningen · NLUniversity of Cape Town · ZA

Funding

Medical Research Council MR/M016579/1
6 · The paper itself

Abstract

In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.

Indexed as

allergen immunotherapyallergic rhinitisasthmaEUFOREApaediatricspatient advisory boardpocket guiderhinosinusitis

Identifiers

PMID37577332
PMCPMC10415067
OpenAlexW4385327181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.